Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
Quant Healthcare Fund - Direct Plan Growth - Growth
Quant Mutual Fund₹18.9794
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +20.41% | — | — |
| 3 year | +21.91% | — | — |
| 5 year | +23.05% | — | — |
All Sectoral Pharma and Healthcare funds · Quant Mutual Fund
Returns
From NAVs through 18 Aug 2026
Calendar years
Rolling 1-year · 25 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
21 holdings · portfolio as on 30 May 2026
- 24.76%Treps 01-Jun-2026 Depo 10
- 9.55%HFCL LtdTechnology
- 9.45%Future on Torrent Pharmaceuticals Ltd
- 9.33%Future on Divi's Laboratories Ltd
- 8.74%Zydus Wellness LtdConsumer Defensive
- 8.73%Aster DM Healthcare Ltd Ordinary SharesHealthcare
- 8.66%Anthem Biosciences LtdHealthcare
- 7.66%SMS Pharmaceuticals LtdHealthcare
- 6.98%Alivus Life Sciences LtdHealthcare
- 5.92%Pfizer LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
7 fund managers
- AKAyusha Kumbhat1.1 years in the industryRuns 25 schemes
- STSandeep Tandon5.8 years in the industryRuns 24 schemes
- YTYug Tibrewal1.0 years in the industryRuns 25 schemes
- APAnkit Pande5.8 years in the industryRuns 25 schemes
- SKSameer Kate1.1 years in the industryRuns 26 schemes
- VPVarun Pattani4.1 years in the industryRuns 25 schemes
- SSSanjeev Sharma11.3 years in the industryRuns 29 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare
Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- regularIDCWQuant Healthcare Fund - Regular Plan IDCW - PayoutNAV ₹15.54
- regularGrowthQuant Healthcare Fund - Regular Plan Growth - GrowthNAV ₹15.54
- directIDCWQuant Healthcare Fund - Direct Plan IDCW - PayoutNAV ₹16.13
FAQ
What is Quant Healthcare Fund - Direct Plan Growth - Growth NAV today?
- The latest NAV of Quant Healthcare Fund - Direct Plan Growth - Growth is ₹18.9794 as on 18 Aug 2026.
How has Quant Healthcare Fund - Direct Plan Growth - Growth performed vs its category?
- 1-year return +20.41%. Past performance does not guarantee future returns.
What are the returns of Quant Healthcare Fund - Direct Plan Growth - Growth?
- Trailing returns from published NAVs: 1 year +20.41%, 3 year +21.91% a year, 5 year +23.05% a year, since our first NAV +23.05% a year. Past performance does not guarantee future returns.
How would a SIP in Quant Healthcare Fund - Direct Plan Growth - Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +21.91%. It is not a forecast.
What is the expense ratio and fund size of Quant Healthcare Fund - Direct Plan Growth - Growth?
- For Quant Healthcare Fund - Direct Plan Growth - Growth, the expense ratio is 1.38% and fund size (AUM) is ₹372.5 Cr.
What is the ISIN of Quant Healthcare Fund - Direct Plan Growth - Growth?
- The ISIN for Quant Healthcare Fund - Direct Plan Growth - Growth is INF966L01CD0.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.
